eyenovia-logo 3

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
EFFECT

EFFECT

Other
S-1

Registration statement for face-amount certificate companies

Registration Statements
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

295 Madison Ave., Suite 2400, New York, NY 10017     +1 (917) 289-1117

[email protected]